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The fundamental problem of the multiple
regression analysis is that parameters
(independent variables) considered
simultaneously cannot be mutually related, Le.,
they should be orthogonal [10,11]. It is difficult, if
at all possible, to find a representative (and
sufficiently large for statistical purposes) set of
readily available and informative patients',
disease and treatment parameters which would
be mutually orthogonal. Therefore, prognostic
indexes derived by means of multiple regression
analysis are of a rather limited reliability.
Problems of intercorrelation and
multicolinearity among independent variables
have often been encountered in science. They
can be eliminated by using the so-called
factorial methods of data analysis, in particular
principal component analysis (PCA). These
methods have recently been popularized
especially in chemistry [12,13]. There is no
need to discuss here the higher algebra which
is the basis of the approach. Advanced
software for personal computers, which are
commonly available, can actually be used in a
"black box" manner.
The idea of a PCA is to reduce the
dimensionality of an original multivariable data
set by finding linear combinations of those
parameters (variables) that explain most of the
variability. Most of the systematic information,
initially dispersed over a large matrix of input
variables (often intercorrelated), is extracted
and condensed in a few calculated abstract
variables by using the PCA. Normally, two
factors (principal components a PCs) are used
to determine an abstract variable plane.
Projections of data points ascribed to individual
objects (patients) and individual input variables
on the plane reflect, in a comprehensive
graphical manner, similarites and disimilarities
among them. In this way, a basic part of
systematic information on the objects and the
variables can be exploited by our mind, which
naturally visualises relationships in up to three
dimensions [14].
It is assumed in this study that the PCA may
appear useful in the search for reliable
prognostic factors in various kinds of cancer.
Using the PCA all types of information on
patients, disease, treatment, etc., can be
exploited by means of a single analysis with
variables ranging from sociological to genetic.
This approach will be presented using
information available for 142 breast cancer
patients after mastectomy, who had been
treated and observed in the Chemotherapy
Ward, of the Wielkopolskie Oncology Center in
Poznan. Mastectomy was done in 1990/1991
in the Surgery Ward of the same institution.
The observation was caried on till 1997.
MATERIALS AND METHODS
Data on 201 patients with breast cancer
were retrospectively collected and analysed.
Considering individual data one has to realize
that drugs, treatment strategy and diagnostic
procedures were those usually applied in
1990-1991. A set of 60 variables was
identified. Those variables were common for
all the patients subjected to PCA. For reasons
of statistical significance, a given variable was
included in the analysis if it recurred at least 6
times. Hence, for instance, the age below 30
years was not an independent variable, and
such patients were excluded from PCA,
because they represented only few cases in
our group of 201. As result, the final matrix of
data subjected to PCA was 142 patients times
60 variables. The variables were defined and
written in 0-1 manner. Exemplary data for
patients Nos. 40, 52 and 99 (typically long
survival) and Nos. 43 and 66 (unexpected
short survival) are given in Table 1.
The principal component analysis of the 142 ~
60 data matrix was performed by means of
Statistics software (StatSoft Inc., Tulsa, OK,
USA), run on a personal computer. It was found
that the two first principal components, PC1 and
PC2, accounted cumulatively for 26% of the
variance of data within all 60 original variables.
The programme calculated contributions to PC1
and PC2 of each original variable, numbered
and listed in Table 1. Using those quantities
(principal component "loadings") the variables
are placed on the plane by means of
coordinates PC1 and PC2 (Figure 1).
Table 1. Variables considered in principal component analysis (PCA) and its values for five selected patients.
Variable Variable Variable Value for Patient
No. Name No. 40 No. 52 No. 99 No. 43 No. 66
1 Age: 31·50 years 0 0 0 1 0
2 Age: 51-60 years 0 1 1 0 1
3 Age: >60 years 1 0 0 0 0
4 Menopause: before 0 0 0 1 0
5 Menopause: during 0 0 0 0 0
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Table 1. Continued.
6 Menopause: after 1 1 1 0 1
7 Hormonal activity: 11-20 years 0 0 0 0 0
8 Hormonal activity: 21-30 years 0 1 0 1 1
9 Hormonal activity: 31-40 years 1 0 1 0 0
10 Number of births: 0 0 0 0 0 0
11 Number of births: 1 0 0 1 0 0
12 Number of births: 2 0 1 0 1 1
13 Number of births: 3 0 0 0 0 0
14 Number of births: >3 1 0 0 0 0
15 No record of breast cancer in I and" generation 1 1 1 1 1
16 Tumor size: <40 mm 0 1 0 0 1
17 Tumor size: >40 mm 1 0 1 1 0
18 Positive lymph nodes: none 0 1 0 0 0
19 Positive lymph nodes: 1·3 0 0 0 1 0
20 Positive lymph nodes: 4-8 1 0 1 0 1
21 Positive lymph nodes: >8 0 0 0 0 0
22 No infiltration of node capsule 0 1 1 0 0
23 No arrest in microvessels 1 1 1 1 1
24 Malignancy: Bloom's degree I 0 0 0 0 0
25 Malignancy: Bloom's degree II 1 0 0 0 0
26 Malignancy: Bloom's degree III 0 1 1 1 1
27 Surgery: Halsted's mastectomy 0 1 0 0 0
28 Surgery: Patey's mastectomy 1 0 1 0 1
29 Surgery: mastectomy 0 0 0 1 0
30 Adjuvant therapy: radiotherapy 1 0 1 0 1
31 Adjuvant therapy: chemotherapy 1 0 1 1 0
32 Adjuvant therapy: hormonotherapy 1 1 1 0 1
33 Adjuvant radiotherapy: none 0 1 0 1 0
34 Adjuvant radiotherapy: scar and 1 0 1 0 1
lymph nodes
35 Adjuvant radiotherapy: peripheral 0 0 0 0 0
lymph nodes
36 No neoadjuvant chemotherapy 1 1 0 1 0
37 Type of adjuvant chemotherapy: none 0 1 0 0 1
38 Type of adjuvant chemotherapy: CMF 1 0 1 1 0
39 Type of adjuvant hormonotherapy: 0 0 0 1 0
none
40 Type of adjuvant hormonotherapy: 1 1 1 0 1
tamoxifen
41 First line treatment: surgery 0 0 0 0 0
42 First line treatment: hormonotherapy 1 1 1 0 0
43 First line treatment: chemotherapy 0 1 1 0 0
44 First line treatment: radiotherapy 0 1 0 0 0
45 Type of first line chemotherapy: 1 0 0 0 0
None
46 Type of first line chemotherapy: 0 1 1 0 0
CMF
47 Type of first line chemotherapy: 0 0 0 0 0
anthracyclines
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Table 1. Continued.
48 Type of first line hormonotherapy: 0 0 0 0 0
none
49 Type of first line hormonotherapy: 0 1 0 0 0
tamoxifen
50 Type of first line hormonotherapy: 1 0 1 0 0
aminogluthetimide
51 Response to first line treatment: 0 0 0 0 0
no response
52 Response to first line treatment: 1 1 0 0 0
4·8 months
53 Second line treatment: 1 1 0 0 0
hormonotherapy
Second line treatment: 0 0 0 0 0
54 chemotherapy
55 Type of second line hormonotherapy: 0 0 0 0 0
none
56 Type of second line hormonotherapy: 0 1 0 0 0
aminogluthemide
57 Type of second line chemotherapy: 1 1 0 0 0
none
58 Type of second line chemotherapy: 0 0 0 0 0
anthracyclines
59 Response to second line treatment: 1 0 0 0 0
no response
60 Third line treatment: 1 0 0 0 0
chemotherapy
42
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Figure 1. Projection of 60 variables listed in Table 1 on the plane with coordinates of the first two principal components, PC1
and PC2, distinguished in the principal component analysis (PCA) of data collected from 142 patients. The right top
section of the chart is enlarged at the bottom of the Figure.
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Figure 2. Projection of 142 patients (described by 60 variables listed in Table 1) on the plane with coordinates of the first two
principal components, PC1 and PC2, distinguished in the principal component analysis (PCA) of the 142 x 60 data
matrix. Blank circles denote patients living longer than 7 years after surgery; shaded circles denote deceased patients.
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RESULTS AND DISCUSSION
The following most evident regularities can
easily be sean in Figure 1. On the left hand
side the chart includes variables with a better
prognosis (especially in the top left section).
On the right hand side (especially in the chart's
bottom section) the variables with poorer
prognosis are grouped. For example, majority
of dots on the left represent variables 37 and
33, indicating that neither chemotherapy nor
radiotherapy was applied. On the left, there is
also variable 18 informing about the absence
of positive lymph nodes, and variable 16
indicating tumor size smaller than 40 mm. The
top left section includes variables 6, 3 and 9
informing, respectively, about the menopause
(its termination), age (over 60 years) and
hormonal activity duration (31-40 years).
On the other hand, majority of dots on the
left represent variables 31 and 38, indicating
the need for adiuvant CMF chemotherapy.
Next to them are variables 30 and 43,
indicating adiuvant radiotherapy and
chemotherapy as a first rate treatments,
respectively. In the bottom right section, there
is variable 4 informing that the patient was
before menopause..As expected, in the right
hand side of Figure 1 there are located
variables: No. 17 indicating tumor size > 40
mm, No. 26 indicating the HI degree of Bloom
malignancy; No. 20 indicating 4-8 positive
lymph nodes, etc.
The above regularities are not controversial
and may be considered as a proof of the PCA
information potential regarding the prognostic
value of individual patient's disease and
treatment variables. Some observations in
Fig~re 1 may be disputable. For example,
vanable 27 is more to the right than variables
29 and 28. This would mean that Halsted
mastectomy provides worse prognosis than
simple mastectomy and the Patey
mastectomy.
Using the PCA one obtains quantitative
information on the similarity of information
provided by given variables: the smaller is the
distance between two variable points the more
similar are the effects of the two variables on
the system. Hence, charts developed for a
series of well-known variables can be used to
calibrate other unknown variables. Our study is
basically methodological, but it demonstrates
simultaneously that this approach can be
applied to a number of now available factors of
sociological, morphologic, molecular genetic
and therapeutic nature.
The principal component analysis also
extracts systematic information on objects
described by sets numerous variables. The
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objects here are patients of the total number of
142. Distribution of patients on a plane with
coordinates PC1 and PC2 can be obtained in
the same way as the distribution of variables.
Such a projection of points assigned to
individual patients is presented in Figure 2.
The chart shows clear cut clustering of patients
surviving (blank circles) and not surviving
(shaded circles) the 7-year period after
mastectomy.
It also shows the exellent prognostic potency
of the PCA performed on the factors listed in
Table 1. Only two patients (Nos. 43 and 66)
have been wrongly classified to the surviving
group, and three patients (Nos. 40, 52 and 99)
to the deceased group. The parameters of
those five outliers are given in Table 1. It is
difficult to draw straightforward conclusions
from such a limited number of cases. It can be
hypothesized, however, that the analysis of the
outliers'specific features, especially that of the
unexpectedly surviving patients, may help to
identify a combination of factors providing a
good prognosis. Moreover, the peA offers a
possibility of testing a practically unlimited
number of either mutually related or unrelated
factors. The presented report is
methodological in nature, and is based on a
limited set of readily available data collected
retrospectively. It would be advisable to use
the PCA to process other large sets of data,
especially series of rationally .designed and
determined data.
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